MPH Medicure Inc.

2.586USD3.700 CAD · TSXV+5.41%Mkt Cap: 26.99M USDP/E: —

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…

Key Statistics

Company
Market Cap26.99M USD
Enterprise Value24.81M USD
Revenue (TTM)22.42M USD
Gross Profit8.21M USD
Net Income (TTM)-4.96M USD
Revenue/Share2.15 USD
Last Price2.586 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58469E4085
Valuation
P/E (Trailing)—
P/E (Forward)-11.94
PEG0.17
EV/EBITDA-6.32
EV/Revenue1.11
P/S1.20
P/B3.34
EPS (TTM)-0.50 USD
EPS (Forward)-0.22 USD
52W Range
0.594270% of range3.460
52W High3.460 USD
52W Low0.5942 USD
Profitability
Gross Margin40.71%
Oper. Margin-22.61%
EBITDA Margin-17.51%
Profit Margin-24.60%
ROE-54.98%
ROA-28.45%
ROIC-69.12%
ROCE-51.65%
Growth
Revenue Growth11.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-391.46K USD
CapEx (TTM)—
FCF Margin0.64%
FCF Yield0.53%
Net Debt-794.11K USD
Net Debt/EBITDA0.20
Net Debt/FCF-5.56
Balance Sheet
Debt/Equity0.07
Current Ratio0.97
Quick Ratio0.61
Book Value/Sh0.78 USD
Cash/Share0.12 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateNov 2, 2012
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.44M
Float5.22M
Insiders27.13%
Institutions22.96%
Short Interest
Short Ratio0.9d
Short % Float0.09%
Short % Out.0.07%
Shares Short6.87K
Short (prev mo.)4.15K
Technical
SMA 502.412 (+7.2%)
SMA 2001.243 (+108.0%)
Beta1.21
S&P 52W Chg12.00%
Avg Vol (30d)7.75K
Avg Vol (10d)7.54K
Technical Indicators
RSI (14)48.6
MACD0.0310
MACD Signal0.1239
MACD Hist.-0.0929
BB Upper3.193 USD
BB Middle2.781 USD
BB Lower2.370 USD
BB Width29.56%
ATR (14)0.1680 USD
Vol Ratio (20d)0.91x

About Medicure (CVE: MPH)

›

Medicure (CVE: MPH) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector.

The shares were at 3.700 CAD on 19 November 2026, up 266.3% over 52 weeks. Its 52-week range is 0.8500 CAD to 4.950 CAD: the price is 25.3% below the high and 335.3% above the low.

Its market capitalisation is 38.61M CAD.

Medicure reports return on equity of -55.0%, an operating margin of -22.6% and revenue up 11.4% year over year.

It holds more cash than debt, a net cash position of 1.14M CAD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. The next earnings report is expected on 19 November 2026.